Growth Metrics

Biofrontera (BFRIW) Shares Outstanding (Weighted Average) (2020 - 2025)

Biofrontera has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $10.2 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $10.2 million for Q4 2025, up 84.4% from a year ago — trailing twelve months through Dec 2025 was $10.2 million (up 84.4% YoY), and the annual figure for FY2025 was $10.2 million, up 84.4%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $10.2 million at Biofrontera, up from $9.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for BFRIW hit a ceiling of $17.1 million in Q1 2022 and a floor of $898444.0 in Q2 2022.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $5.2 million (2024), compared with a mean of $5.7 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): soared 799900.0% in 2021 and later plummeted 92.2% in 2023.
  • Biofrontera's Shares Outstanding (Weighted Average) stood at $8.8 million in 2021, then plummeted by 88.0% to $1.1 million in 2022, then skyrocketed by 46.29% to $1.5 million in 2023, then surged by 256.74% to $5.5 million in 2024, then surged by 84.4% to $10.2 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $10.2 million (Q4 2025), $9.7 million (Q3 2025), and $9.1 million (Q2 2025) per Business Quant data.